Background: Heart rate variability (HRV) measurements provide a low-cost, physiological,non-invasive method for assessing cardiac autonomic function. Lower than normal HRV values are typical in patients with advanced chronic systolic heart failure(HF) (NYHA III-IV), and have been shown to be associated with a higher occurrence of sudden death in these patients. There is limited data investigating whether acute HRV measurements may be useful in predicting CHFdecompensation in patients with chronic systolic heart failure. Current biventricular devices have the ability to monitor HRV (time domain measures) on a daily basis. Furthermore, HRV measurements have never been correlated to acute changes in volume, which may help predict and guide heart failure managementonondailybasis.
